Results 1 to 10 of about 76,618 (225)
Objective: To evaluate the effectiveness of etanercept in the treatment of refractory recurrent spontaneous abortion with innate immune disorders. Materials and methods: A randomized controlled trial in patients with refractory innate immune RSA was ...
Jinhua Fu, Lin Li, Lijuan Qi, Long Zhao
doaj +1 more source
Etanercept therapy in rheumatoid arthritis: Efficacy and safety [PDF]
Introduction. Etanercept, tumor necrosis factor (TNFα) antagonist, lowers the disease activity level in patients with rheumatoid arthritis (RA), reduces joint destruction saving physical functions and improving life quality. Objective. The aim of this
Ilić Tatjana +4 more
doaj +1 more source
Myelodysplasia in a psoriasis patient receiving etanercept : Cause or coincidence? [PDF]
Peer reviewedFinal Accepted ...
Ayoub, Othman Hadi +3 more
core +3 more sources
Treatment recommendations for psoriatic arthritis [PDF]
Objective: To develop comprehensive recommendations for the treatment of the various clinical manifestations of psoriatic arthritis (PsA) based on evidence obtained from a systematic review of the literature and from consensus opinion.
Ritchlin, CT +15 more
core +1 more source
The article presents a case of polyarticular juvenile idiopathic arthritis resistant to methotrexate therapy and nonsteroidal antiinflammatory drugs. The child was prescribed a tumor necrosis factor inhibitor etanercept at a dose of
Anna V. Karaseva +2 more
doaj +1 more source
Secukinumab versus adalimumab for psoriatic arthritis: comparative effectiveness up to 48 weeks using a matching-adjusted indirect comparison [PDF]
Secukinumab and adalimumab are approved for adults with active psoriatic arthritis (PsA). In the absence of direct randomized controlled trial (RCT) data, matching-adjusted indirect comparison can estimate the comparative effectiveness in anti-tumor ...
Gandhi, Kunal +8 more
core +2 more sources
Background The advent of biosimilars may increase the frequency of dose escalation with biologics in psoriasis.Objective To explore the frequency and outcomes of dose escalation with adalimumab etanercept, and ustekinumab.Methods Data were extracted from
Axel Svedbom +4 more
doaj +1 more source
Circulating Tumour Necrosis Factor is highly correlated with brainstem serotonin transporter availability in humans [PDF]
Preclinical studies demonstrate that pro-inflammatory cytokines increase serotonin transporter availability and function, leading to depressive symptoms in rodent models.
Burden, A. David +10 more
core +1 more source
Objective ― The aim of the study was to investigate the relationship of the alleles and genotypes of the immune response mediator genes polymorphic loci (rs1800629, rs909253, rs16944, rs6822844, rs2104286, rs1800795, rs1800872, rs3087243, rs755622 ...
Liliia Sh. Nazarova +4 more
doaj +1 more source
New insights into the impact of neuro-inflammation in rheumatoid arthritis. [PDF]
Rheumatoid arthritis (RA) is considered to be, in many respects, an archetypal autoimmune disease that causes activation of pro-inflammatory pathways resulting in joint and systemic inflammation.
Akasbi +102 more
core +2 more sources

